Vaccines

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains a biological preparation from disease-causing microorganism, or since the beginning of the 21st century, made synthetically that resembles it. This preparation is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat and starts producing antibodies against it, so as to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in …

Wikipedia

Publications

IRENA: International Renewable Energy Agency · 11 June 2024 English

Renewable energy, energy access

operation of medical equipment and refrigeration of vaccines. Most unelectrified public institutions are in


WHO: World Health Organization · 7 June 2024

12 p

risk of rabies. Safe, effective human and dog vaccines and understanding of disease trans- mission dynamics to affordable PEP and has included PEP rabies vaccines in its vaccine investment strategy 2021–2025 replace intra- muscular administration of PEP vaccines with intrader- mal regimens, which are shorter rabies to hepatitis: Gavi to start rolling out new vaccines to lower-income countries. Geneva: Gavi, the woah.org/en/disease/rabies/#ui-id-2). 17 Rabies vaccines: WHO position paper. Geneva: World Health Organization


WHO: World Health Organization · 7 June 2024

12 p

risk of rabies. Safe, effective human and dog vaccines and understanding of disease trans- mission dynamics to affordable PEP and has included PEP rabies vaccines in its vaccine investment strategy 2021–2025 replace intra- muscular administration of PEP vaccines with intrader- mal regimens, which are shorter rabies to hepatitis: Gavi to start rolling out new vaccines to lower-income countries. Geneva: Gavi, the woah.org/en/disease/rabies/#ui-id-2). 17 Rabies vaccines: WHO position paper. Geneva: World Health Organization


World Bank Group · 6 June 2024 English

to procure 20 million doses of A nthrax spore vaccines, vacci nation consumables, and logi stics for


RAND Corporation · 6 June 2024 English

Environmental sampling surveillance (ESS) technologies provide valuable information for pandemic response. Using the COVID-19 pandemic as a base-case scenario, this paper presents a model to quantify the value provided by …

only simulate the benefit of the system before vaccines are expected to be available. We also do not


EPRS: European Parliamentary Research Service · 6 June 2024 English

Amidst a changed global environment and with the goal to defend its geopolitical weight, the EU should provide public goods with EU value added, so that efficiency gains can be …

Member States as evidenced by the joint orders of vaccines throughout the pandemic. Given the current


ADB: Asian Development Bank · 5 June 2024 English

This brief analyzes how Bangladesh can strengthen its regulatory ecosystem to bolster vaccine and pharmaceutical manufacturing, improve public health outcomes, and better prepare for future health emergencies.

2024 Strengthening the Regulatory Ecosystem for Vaccines in Bangladesh: Landscape and Policy Recommendations safe and effective medical products, including vaccines. Bangladesh aims to strengthen its regulatory could foster a strong regulatory ecosystem for vaccines and other pharma products in Bangladesh. ISBN INTRODUCTION Access to safe and effective drugs, vaccines, and therapeutics is crucial for public health population lacks timely access to quality-assured vaccines and other pharmaceutical products (footnote 1)


World Bank Group · 5 June 2024 English

2023-10-20 LR-MOHSW-341085-GO-DIR / Procurement of Vaccines - An tigens & Injection supplies IDA / 72070 Component


World Bank Group · 5 June 2024 English

Development Agency (NPHCDA) GOODS 1 Procurement of vaccines and devices for immunization Prior 61,380,767


World Bank Group · 4 June 2024 English

Health care systems must be prepared to address the expanding and complex needs of an aging population. Rather than a “silver challenge,” this situation should be seen as an opportunity …

competency of health workforce, supply of drugs, vaccines, technologies, assistive devices, service delivery);


View more